Title: Finding common ground: the key to successful partnership
1Finding common ground the key to successful
partnership
Ginny Valenze Roche USA
2Finding Common GroundThe Key to Successful
Partnership
- Virginia Valenze
- Director, US Public Affairs
- Buildling Partnerships in Breast Cancer 2005
- November 2, 2005
3Defining Advocacy Partnership Criteria
- Roche Advocacy partnerships include those
resources that support the principles of Roche
by - Building valuable relationships with key opinion
leaders, customers, patients, healthcare
professionals, employees and communities - Supporting solutions to issues facing our
customers, internal business needs - Directing funds to qualified charitable,
educational, patient and health organizations
4Advocacy Objectives
- Develop and implement strategies and proactive
programs that - Create strong partnerships and alliances with key
opinion leaders and stakeholders - Provide platforms for optimum media exposure
- Enable access to key thoughtleaders,
decisionmakers - Demonstrate our corporate citizenship commitment
- Partner to leverage advocacy and corporate
resources
5Advocacy Program Drivers
- Leadership through distinctive and unique
programs with impact - Business alignment
- Innovation
- Integrity
- Partnerships and teamwork
- Diversity
- Employee involvement where appropriate
6Build relationships earlyAdvocacy growth cycle
3 Years Pre-Launch
2 Years Pre-Launch
1 Year Pre-Launch
Product Launch
Post Launch
Begin Relationship Building
Activity Planning
Activity Implementation
Evaluation
7Public Affairs Advocacy Touch Many Audiences
Support Public Policy Legislative Initiatives
Media Relations Outreach
Create Patient Education Programs Materials
Public Affairs Advocacy
Communicate Key Issues to Key audiences
Build Patient Professional Relationships
POSITIVELY IMPACT PATIENTS LIVES
Leverage Medical Meetings Congresses
8Trans-Atlantic Advocacy in Action
We took a popular American abroad
and
gave her an English voice!
9Cosmetic Executive WomenCancerandcareers
Carlotta Jacobson President CEO Cosmetic
Executive Women
A Letter from the UK
10Birth of the US Roche Oncology Advocacy Advisory
Board at ASCO
- Provides needed forum for open discussion and
frank dialogue on relevant issues - Take advantage of leading global oncology meeting
environment - Opportunity for critical feedback to assess value
of future investments - Confirms true partnership on behalf of patients
- Most importantly, provides platform to inform,
educate and subsequently forge and enhance
alliances prior to major announcements
11ASCO Advocacy Advisory Board Specific Objectives
- Learn the best ways to disseminate breaking news
and important updates to advocacy members,
patients and caregivers - Seek comments on existing patient information in
order to improve effectiveness and use/uptake in
advocacy community - Gain insight to advocacy perspective and
expertise with regard to key issues that might be
critical to cancer patients - How to best communicate information on clinical
trials
12Metastatic Bone Pain Often Viewed As a Death
Sentence
13The Advocacy Attendees
14The Attendees
- 10 Major US Advocacy Leaders
- 5 Roche personnel
- 3 Uninterrupted Hours
- 1 Internationally renowned KOL
- 1 Room
15The Way We Help Each Other
- Media CRPF CEO advocacy spokesperson quoted
worldwide in press coverage - Public Policy Colon Cancer Alliance panel
participant in critical US Congressional Briefing
on CRC - Marketing Patient Material Development Advisory
Board to participate as editorial board for
second printing of Cancer Companion (patient
education kit originally) - Medical KOL Thoughtleader Involvement Howard
Burris (lead clinical investigator) featured in
CancerCare teleconference workshop on new
adjuvant treatment options for CRC attended by
more than 700 healthcare professionals - Trial Information Disseminated Eleven leading
national advocacy groups will list information on
MBP clinical trial on their websites and
disseminate recruitment information-reaching
significant patient numbers
16Next Steps
- Integrate learnings into future strategic Roche
plans - Ensure ongoing two-way communication with
advocacy partners on advisory board - Continue to evaluate/leverage feedback
- Expand to twice yearly meetings
17 18(No Transcript)